Msika wogulitsa, kusinthanitsa kwa malonda lero
Mndandanda wamagulu a makampani 71229 mu nthawi yeniyeni.
Msika wogulitsa, kusinthanitsa kwa malonda lero

Zotsatira zamagulu

Mavesi a pa Intaneti

Mbiri yotsatsa zamagulu

Msika wamsika wogulitsa

Zogulitsa Zamagulu

Phindu kuchokera kumagulu a kampani

Malipoti a zachuma

Kuwerengera magawo a makampani. Kumene mungayendetse ndalama?

Mirati Therapeutics, Inc. kapu yamsika

Mtengo wa malonda a Mirati Therapeutics, Inc. lero ndi mbiri ya ndalama zambiri za Mirati Therapeutics, Inc. kuyambira pachiyambi cha malonda mu magawo a MRTX pa malonda.
Onjezani ku ma widget
Kuwonjezeka ku ma widgets

Mirati Therapeutics, Inc. ndalama zazikulu

Lero msika wamsika wa Mirati Therapeutics, Inc. ndi 2 609 465 600 Dollar US.
-6 971 136 $ (-0.27%)
kusintha kwa ndalama kuyambira dzulo

Zambiri zakukula kwa kusintha kwa Mirati Therapeutics, Inc. capitalization imawerengeredwa kamodzi patsiku. Zambiri za Mirati Therapeutics, Inc. zimatengedwa kuchokera kochokera. Zambiri zakatundu wa Mirati Therapeutics, Inc. ndizongotchulidwira. Mirati Therapeutics, Inc., capitalization - 2 609 465 600 madola aku US.

Mirati Therapeutics, Inc. kuchuluka kwa malonda

Masiku ano gawo la malonda Mirati Therapeutics, Inc. limakhala 144 886 Dollar US.
-542 785 $ (-78.93%)
kusintha kwa malonda a malonda kuyambira dzulo

Mirati Therapeutics, Inc. kuchuluka kwa malonda lero - 144 886 US dollars. Mirati Therapeutics, Inc. imagulitsidwa pamisika yosiyanasiyana yosinthanitsa. Mirati Therapeutics, Inc. tchati cha malonda chili patsamba lathu tsiku lililonse. Mtengo wa zonse Mirati Therapeutics, Inc. masheya omwe atulutsidwa (Mirati Therapeutics, Inc.) adatsika ndi $ -6 971 136.

Onetsani:
Kuti

Mirati Therapeutics, Inc. chithunzi chachitsulo cha msika

Kusintha kwa m'magawo a Mirati Therapeutics, Inc. patali sabata iliyonse ndi 2.87%. Pakupita kwa mwezi, Mirati Therapeutics, Inc. yasintha mwa 0%. Pazaka zambiri, Mirati Therapeutics, Inc. yasintha ndi -0.27%. Lero, Mirati Therapeutics, Inc. ikuyerekeza pamakampani a 2 609 465 600 US dollars.

Sabata Mwezi miyezi 3 Chaka Zaka 3

Mirati Therapeutics, Inc. mbiri yakale

Date Kulipira ndalama
Ndalama zamtengo wapatali (malonda a msika) ndi mtengo wamsika wa magawo onse a makampani ogulitsa malonda. Ndalama zamsika zimakhala zofanana ndi mtengo wa magawo owonjezeka ndi chiwerengero cha magawo omwe apambana.
04/05/2023 2 609 465 600 $
03/05/2023 2 616 436 736 $
02/05/2023 2 571 706 368 $
01/05/2023 2 665 233 408 $
28/04/2023 2 587 100 416 $
27/04/2023 2 506 353 408 $
26/04/2023 2 536 579 840 $

Chitsulo cha voti Mirati Therapeutics, Inc.

Sabata Mwezi miyezi 3 Chaka Zaka 3

Mirati Therapeutics, Inc. deta yakale ya mbiri yakale

Date Volume (24h)
Mndandanda wa malonda a Mirati Therapeutics, Inc. magawo ndi chiwerengero chazogulitsa zonse ndi magawo a MRTX ogula ndi kugulitsidwa pa tsiku losankhidwa.
04/05/2023 144 886 $
03/05/2023 687 671 $
02/05/2023 307 495 $
01/05/2023 767 769 $
28/04/2023 218 361 $
27/04/2023 73 194 $
26/04/2023 400 139 $

Mirati Therapeutics, Inc. capitalization pamsika ku 04/05/2023 ilingana ndi 2 609 465 600 US dollars. 03/05/2023 Mirati Therapeutics, Inc. ndiyofanana 2 616 436 736 madola aku US. 02/05/2023 Mirati Therapeutics, Inc. ndiyofanana 2 571 706 368 madola aku US. Kuyatsa 01/05/2023, Mirati Therapeutics, Inc. kunali $ 2 665 233 408.

28/04/2023 Mirati Therapeutics, Inc. ndiyofanana 2 587 100 416 madola aku US. Msika wamalonda wa Mirati Therapeutics, Inc. inakwana 2 506 353 408 madola aku US ku 27/04/2023. Msika wamalonda wa Mirati Therapeutics, Inc. inakwana 2 536 579 840 madola aku US ku 26/04/2023.

Ndalama zamakono za Mirati Therapeutics, Inc. lero ndi 2 609 465 600 $. Msika wamsika wa Mirati Therapeutics, Inc. wasintha -0.266% poyerekeza ndi dzulo. Mndandanda wamalonda wa magawo MRTX, Mirati Therapeutics, Inc. pa tsiku lomalizira la malonda unali 144 886 $. Mndandanda wamalonda wa magawo Mirati Therapeutics, Inc. wasintha kufika pa -78.931% poyerekeza ndi tsiku lapitalo la malonda.

Mtengo wa magawo Mirati Therapeutics, Inc.

Finance Mirati Therapeutics, Inc.